New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export AMGN’s income statement to Excel — free account
Amgen Inc.
AMGNHealthcare Drug Manufacturers General
Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024.
- Revenue
- +8.45%
- EPS
- +19.4%
- Free cash flow
- −14.0%
- Total debt
- −1.06%
Quarter to September 2026, against a year earlier
439.53
0.73
+0.17%
Follow AMGN
Alert me
Amgen Inc. (AMGN) SEC filings, changes and red flags
Red flags
-
Officer departure
Amgen Inc. reported the departure of an officer or director
-
Cybersecurity incident
Amgen Inc. reported a material cybersecurity incident
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 10-Q | Sep 30, 2026 |
P1I2: 16 added · 9 removed · 56 modified P2I1A: 1 added · 38 removed · 17 modified |
||
| 8-K | Nov 3, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Oct 26, 2026 | 5.02 Departure or appointment of directors or officers | Officer departure | |
| 10-Q | Jun 30, 2026 |
P1I2: 13 added · 6 removed · 63 modified P2I1A: 26 added · 9 removed · 24 modified |
||
| 8-K | Aug 4, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Jul 29, 2026 | 1.05 Material cybersecurity incident | Cybersecurity incident | |
| 8-K | May 19, 2026 | 5.07 Submission of matters to a vote of security holders | ||
| 8-K | May 19, 2026 | 5.02 Departure or appointment of directors or officers | ||
| 10-Q | Mar 31, 2026 |
P1I2: 22 added · 33 removed · 53 modified P2I1A: 61 added |
||
| 8-K | Apr 30, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 22, 2026 | 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 17, 2026 | 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2025 |
1: 32 added · 28 removed · 84 modified 1A: 9 added · 9 removed · 99 modified 7: 30 added · 18 removed · 74 modified |
||
| 8-K | Feb 3, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Jan 30, 2026 | 1.02 Termination of a material definitive agreement; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2025 |
P1I2: 13 added · 17 removed · 58 modified P2I1A: 41 removed · 12 modified |
||
| 8-K | Nov 4, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2025 |
P1I2: 26 added · 9 removed · 50 modified P2I1A: 43 added · 32 removed · 12 modified |
||
| 8-K | Aug 5, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 31, 2025 |
P1I2: no comparison — the earlier filing's text is no longer kept P2I1A: 58 added |
||
| 8-K | May 1, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2024 |
1: no comparison — no earlier filing on file 1A: no comparison — no earlier filing on file 7: no comparison — no earlier filing on file |
||
| 8-K | Feb 4, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2024 | |||
| 8-K | Oct 30, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2024 | |||
| 8-K | Aug 6, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | May 2, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 6, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits |